<bill session="108" type="s" number="191" updated="2023-01-15T21:34:09Z">
  <state datetime="2003-01-16">REFERRED</state>
  <status>
    <introduced datetime="2003-01-16"/>
  </status>
  <introduced datetime="2003-01-16"/>
  <titles>
    <title type="display">Immunosuppressive Drug Coverage Act of 2003</title>
    <title type="official" as="introduced">A bill to amend title XVIII of the Social Security Act to provide adequate coverage for immunosuppressive drugs furnished to beneficiaries under the medicare program that have received a kidney transplant, and for other purposes.</title>
    <title type="short" as="introduced">Immunosuppressive Drug Coverage Act of 2003</title>
  </titles>
  <sponsor bioguide_id="D000294"/>
  <cosponsors/>
  <actions>
    <action datetime="2003-01-16">
      <text>Introduced in Senate</text>
    </action>
    <action datetime="2003-01-16">
      <text>Sponsor introductory remarks on measure.</text>
      <reference ref="CR S1082"/>
    </action>
    <action datetime="2003-01-16" state="REFERRED">
      <text>Read twice and referred to the Committee on Finance.</text>
    </action>
  </actions>
  <committees>
    <committee code="SSFI" name="Senate Finance" subcommittee="" activity="Referral"/>
  </committees>
  <relatedbills/>
  <subjects>
    <term name="Health"/>
    <term name="Coinsurance"/>
    <term name="Employee health benefits"/>
    <term name="Finance and Financial Sector"/>
    <term name="Health insurance"/>
    <term name="Hospital care"/>
    <term name="Immunosuppressive drugs"/>
    <term name="Insurance premiums"/>
    <term name="Kidney diseases"/>
    <term name="Labor and Employment"/>
    <term name="Medicare"/>
    <term name="Social Welfare"/>
    <term name="Transplantation of organs, tissues, etc."/>
  </subjects>
  <amendments/>
  <summary date="2006-11-28T17:35:40Z" status="Introduced in Senate">Immunosuppressive Drug Coverage Act of 2003 - Amends title II (Old Age, Survivors and Disability Insurance) (OASDI) of the Social Security Act to: (1) continue entitlement to prescription drugs used in immunosuppressive therapy furnished to an individual who receives a kidney transplant for which payment is made under Medicare; and (2) extend Medicare secondary payer requirements for end stage renal disease beneficiaries.Amends the Public Health Service Act, the Employee Retirement Income Security Act of 1974, and the Internal Revenue Code to set forth requirements for group health plans to provide coverage of immunosuppressive drugs.</summary>
</bill>
